Wide Spectrum of Inhibitory Effects of Sertraline on Cardiac Ion Channels |
Lee, Hyang-Ae
(Next-Generation Pharmaceutical Research Center, Korea Institute of Toxicology, Korea Research Institute of Chemical Technology)
Kim, Ki-Suk (Next-Generation Pharmaceutical Research Center, Korea Institute of Toxicology, Korea Research Institute of Chemical Technology) Hyun, Sung-Ae (Next-Generation Pharmaceutical Research Center, Korea Institute of Toxicology, Korea Research Institute of Chemical Technology) Park, Sung-Gurl (Next-Generation Pharmaceutical Research Center, Korea Institute of Toxicology, Korea Research Institute of Chemical Technology) Kim, Sung-Joon (Department of Physiology and Department of Biomedical Sciences, Seoul National University College of Medicine) |
1 | Nabauer M, Kaab S. Potassium channel down-regulation in heart failure. Cardiovasc Res. 1998;37:324-334. DOI ScienceOn |
2 | Tsuboi M, Antzelevitch C. Cellular basis for electrocardiographic and arrhythmic manifestations of Andersen-Tawil syndrome (LQT7). Heart Rhythm. 2006;3:328-335. DOI ScienceOn |
3 | Grant AO, Carboni MP, Neplioueva V, Starmer CF, Memmi M, Napolitano C, Priori S. Long QT syndrome, Brugada syndrome, and conduction system disease are linked to a single sodium channel mutation. J Clin Invest. 2002;110:1201-1209. DOI |
4 | Splawski I, Timothy KW, Decher N, Kumar P, Sachse FB, Beggs AH, Sanguinetti MC, Keating MT. Severe arrhythmia disorder caused by cardiac L-type calcium channel mutations. Proc Natl Acad Sci USA. 2005;102:8089-8096. DOI ScienceOn |
5 | Pacher P, Ungvari Z, Nanasi PP, Furst S, Kecskemeti V. Speculations on difference between tricyclic and selective serotonin reuptake inhibitor antidepressants on their cardiac effects. Is there any? Curr Med Chem. 1999;6:469-480. |
6 | De Ponti F, Poluzzi E, Cavalli A, Recanatini M, Montanaro N. Safety of non-antiarrhythmic drugs that prolong the QT interval or induce torsade de pointes: an overview. Drug Saf. 2002;25:263-286. DOI ScienceOn |
7 | Haddad PM, Anderson IM. Antipsychotic-related QTc prolongation, torsade de pointes and sudden death. Drugs. 2002;62: 1649-1671. DOI ScienceOn |
8 | Witchel HJ, Hancox JC, Nutt DJ. Psychotropic drugs, cardiac arrhythmia, and sudden death. J Clin Psychopharmacol. 2003; 23:58-77. DOI ScienceOn |
9 | Li GR, Lau CP, Ducharme A, Tardif JC, Nattel S. Transmural action potential and ionic current remodeling in ventricles of failingcanine hearts. Am J Physiol Heart Circ Physiol. 2002; 283:H1031-1041. DOI |
10 | Jiang M, Zhang M, Tang DG, Clemo HF, Liu J, Holwitt D, Kasirajan V, Pond AL, Wettwer E, Tseng GN. KCNE2 protein is expressed in ventricles of different species, and changes in its expression contribute to electrical remodeling in diseased hearts. Circulation. 2004;109:1783-1788. DOI ScienceOn |
11 | Viskin S. Long QT syndromes and torsade de pointes. Lancet. 1999;354:1625-1633. DOI ScienceOn |
12 | Kannankeril PJ, Roden DM. Drug-induced long QT and torsade de pointes: recent advances. Curr Opin Cardiol. 2007;22:39-43. DOI ScienceOn |
13 | Witchel HJ, Hancox JC, Nutt DJ. Psychotropic drugs, cardiac arrhythmia, and sudden death. J Clin Psychopharmacol. 2003;23:58-77. DOI ScienceOn |
14 | Glassman AH, Bigger JT Jr. Cardiovascular effects of therapeutic doses of tricyclic antidepressants. A review. Arch Gen Psychiatry. 1981;38:815-820. DOI ScienceOn |
15 | Yeragani VK, Roose S, Mallavarapu M, Radhakrishna RK, Pesce V. Major depression with ischemic heart disease: effects of paroxetine and nortriptyline on measures of nonlinearity and chaos of heart rate. Neuropsychobiology. 2002;46:125-135. DOI ScienceOn |
16 | Yeragani VK. Major depression and long-term heart period variability. Depress Anxiety. 2000;12:51-52. DOI ScienceOn |
17 | Rodriguez de la Torre B, Dreher J, Malevany I, Bagli M, Kolbinger M, Omran H, Luderitz B, Rao ML. Serum levels and cardiovascular effects of tricyclic antidepressants and selective serotonin reuptake inhibitors in depressed patients. Ther Drug Monit. 2001;23:435-440. DOI ScienceOn |
18 | de Boer RA, van Dijk TH, Holman ND, van Melle JP. QT interval prolongation after sertraline overdose: a case report. BMC Emerg Med. 2005;5:5. DOI ScienceOn |
19 | Pousti A, Bakhtiarian A, Najafi R, Deemyad T, Brumand K, Hosseini MJ. Effect of sertraline on ouabain-induced arrhythmia in isolated guinea-pig atria. Depress Anxiety. 2009;26: E106-110. DOI ScienceOn |
20 | Amin M, Lehmann H, Mirmiran J. A double-blind, placebocontrolled dose-finding study with sertraline. Psychopharmacol Bull. 198925:164-167. |
21 | Kocabay G, Yildiz M, Eksi Duran N, Ozkan M. Sinus arrest due to sertraline. Clin Cardiol. 2010;33:E114-115. DOI ScienceOn |
22 | Patel NH, Golwala H, Stavrakis S, Schechter E. Sertraline-Induced Ventricular Tachycardia. Am J Ther. 2011. [Epub ahead of print] |
23 | Hoehns JD, Fouts MM, Kelly MW, Tu KB. Sudden cardiac death with clozapine and sertraline combination. Ann Pharmacother. 2001;35:862-866. DOI |
24 | Keating MT, Sanguinetti MC. Molecular and cellular mechanisms of cardiac arrhythmias. Cell. 2001;104:569-580. DOI ScienceOn |
25 | Tseng GN. I(Kr): the hERG channel. J Mol Cell Cardiol. 2001;33:835-849. DOI ScienceOn |
26 | Saldeen J, Curiel DT, Eizirik DL, Andersson A, Strandell E, Buschard K, Welsh N. Efficient gene transfer to dispersed human pancreatic islet cells in vitro using adenovirus-polylysine/ DNA complexes or polycationic liposomes. Diabetes. 1996; 45:1197-1203. DOI ScienceOn |
27 | Hamill OP, Marty A, Neher E, Sakmann B, Sigworth FJ. Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches. Pflugers Arch. 1981;391:85-100. DOI ScienceOn |
28 | Fisch C, Knoebel SB. Electrocardiographic findings in sertraline depression trials. Drug Invest. 19924:305-312. DOI |
29 | Park KS, Kong ID, Chung HS, Joo NY, Park KC, Lee JW. Effects of antidepressants on cardiac functions in the perfused rat heart. J Wonju Coll Med J. 1996;9:176-181 |
30 | Park KS, Kong ID, Park KC, Lee JW. Fluoxetine inhibits L-type and transient outward currents in rat ventricular myocytes. Yonsei Med J. 199940:144-151. DOI |
31 | Amin M, Lehmann H, Mirmiran J. A double-blind, placebocontrolled dose-finding study with sertraline. Psychopharmacol Bull. 1989;25:164-167. |
32 | Wang GK, Mitchell J, Wang SY. Block of persistent late currents by antidepressant sertraline and paroxetine. J Membr Biol. 2008;222:79-90. DOI ScienceOn |
33 | Meijer WE, Heerdink ER, Leufkens HG, Herings RM, Egberts AC, Nolen WA. Incidence and determinants of long-term use of antidepressants. Eur J Clin Pharmacol. 2004;60:57-61. DOI ScienceOn |
34 | Kelsey JE, Nemeroff CB. Selective serotonin reuptake inhibitors: introduction and overview. In: Sadock BJ, Sadock VA, ed. Philadelphia PA: Lippincott Williams & Willis; 2000. p.2432-2435. |
35 | Maertens C, Droogmans G, Verbesselt R, Nilius B. Block of volume-regulated anion channels by selective serotonin reuptake inhibitors. Naunyn Schmiedebergs Arch Pharmacol. 2002; 366:158-165. DOI ScienceOn |
36 | Kobayashi T, Washiyama K, Ikeda K. Inhibition of G proteinactivated inwardly rectifying channels by different classes of antidepressants. PLoS One. 2011;6:e28208. DOI |
37 | Sanguinetti MC, Jiang C, Curran ME, Keating MT. A mechanistic link between an inherited and an acquired cardiac arrhythmia: HERG encodes the IKr potassium channel. Cell. 1995;81:299-307. DOI ScienceOn |
38 | http://www.pfizer.ca/en/our_products/products/monograph/137/ May 2010 |
39 | Redfern WS, Carlsson L, Davis AS, Lynch WG, MacKenzie I, Palethorpe S, Siegl PK, Strang I, Sullivan AT, Wallis R, Camm AJ, Hammond TG. Relationships between preclinical cardiac electrophysiology, clinical QT interval prolongation and torsade de pointes for a broad range of drugs: evidence for a provisional safety margin in drug development. Cardiovasc Res. 2003;58: 32-45. DOI ScienceOn |
40 | Chen J, Zheng R, Melman YF, McDonald TV. Functional interactions between KCNE1 C-terminus and the KCNQ1 channel. PLoS One. 2009;4:e5143. DOI ScienceOn |